News and Community

Antibody Drug Conjugate, Enhertu, Eu Approval, Healthcare Technology, Her2 Positive Cancer Treatment, Tumor Agnostic Therapy

June 29, 2026

Enhertu® Gains EU Approval as First Tumor Agnostic HER2 Directed Therapy for Solid Tumors